PLUR
PLUR
NASDAQ · Biotechnology

Pluri Inc

$1.06
-0.01 (-0.93%)
As of Sep 22, 5:10 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,907.5% upside
Low Target $23.35
Average Target $42.48
High Target $52.53
Current Price $1.06
Current
$1.06
Target
$42.48
$23.35 $42.48 avg $52.53
Scenario Analysis
Bear Case
$23.35
2,102.8%
Low target
Base Case
$42.48
+3,907.5%
Avg target
Bull Case
$52.53
+4,855.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$4.96
-78.6% from high
52-Week Low
$1.06
+0.0% from low
Target vs 52W High
$42.48
+756.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.0%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -15.6%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.5%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%